about
sameAs
PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic SyndromeTargeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of HypertensionMaternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later LifeInterplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients.Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction.High Fat Diets Sex-Specifically Affect the Renal Transcriptome and Program Obesity, Kidney Injury, and Hypertension in the Offspring.Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease.Renal Transcriptome Analysis of Programmed Hypertension Induced by Maternal Nutritional Insults.Maternal Melatonin Therapy Rescues Prenatal Dexamethasone and Postnatal High-Fat Diet Induced Programmed Hypertension in Male Rat OffspringIncidence and Risks of Congenital Anomalies of Kidney and Urinary Tract in Newborns: A Population-Based Case-Control Study in TaiwanIncidence, Outcomes, and Risk Factors of Community-Acquired and Hospital-Acquired Acute Kidney Injury: A Retrospective Cohort StudyAliskiren Administration during Early Postnatal Life Sex-Specifically Alleviates Hypertension Programmed by Maternal High Fructose Consumption.N-acetylcysteine prevents hypertension via regulation of the ADMA-DDAH pathway in young spontaneously hypertensive ratsDevelopmental Origins of Chronic Kidney Disease: Should We Focus on Early Life?Developmental Programming of Adult Disease: Reprogramming by Melatonin?Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA).Resveratrol prevents the combined maternal plus postweaning high-fat-diets-induced hypertension in male offspring.Maternal melatonin or N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and renal transcriptome to prevent prenatal NG-Nitro-L-arginine-methyl ester (L-NAME)-induced fetal programming of hypertension in adult male offspring.RNA silencing targeting PIN (protein inhibitor of neuronal nitric oxide synthase) attenuates the development of hypertension in young spontaneously hypertensive rats.N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers.Compliance with risk management plan recommendations on laboratory monitoring of antitumor necrosis factor-α therapy in clinical practice.Homocysteine and Arginine-to-Asymmetric Dimethylarginine Ratio Associated With Blood Pressure Abnormalities in Children With Early Chronic Kidney Disease.Maternal citrulline supplementation prevents prenatal N(G)-nitro-L-arginine-methyl ester (L-NAME)-induced programmed hypertension in rats.Estimation of CML incidence: disagreement between national cancer registry and health claims data system in Taiwan.High citrulline-to-arginine ratio associated with blood pressure abnormalities in children with early chronic kidney disease.Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.Early short-term treatment with exogenous hydrogen sulfide postpones the transition from prehypertension to hypertension in spontaneously hypertensive rat.Maternal melatonin or agomelatine therapy prevents programmed hypertension in male offspring of mother exposed to continuous light.Early Supplementation of d-Cysteine or l-Cysteine Prevents Hypertension and Kidney Damage in Spontaneously Hypertensive Rats Exposed to High-Salt Intake.Risk of tuberculosis comparison in new users of antitumour necrosis factor-α and with existing disease-modifying antirheumatic drug therapy.EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney disease.Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions.Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis.Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins.Maternal Administration of Probiotic or Prebiotic Prevents Male Adult Rat Offspring against Developmental Programming of Hypertension Induced by High Fructose Consumption in Pregnancy and LactationDevelopmental Programming of the Metabolic Syndrome: Can We Reprogram with Resveratrol?Maternal Resveratrol Therapy Protects Male Rat Offspring against Programmed Hypertension Induced by TCDD and Dexamethasone Exposures: Is It Relevant to Aryl Hydrocarbon Receptor?AMP-Activated Protein Kinase as a Reprogramming Strategy for Hypertension and Kidney Disease of Developmental OriginPostnatal high-fat diet sex-specifically exacerbates prenatal dexamethasone-induced hypertension: Mass spectrometry-based quantitative proteomic approach
P50
Q26771825-705D90CA-C6D8-4CA9-83C8-3684415D0E6CQ28069733-3DC35581-C147-455B-815C-0436323A448EQ28075190-3C035E0B-A6A0-473E-8011-C1EF635F00DBQ30234757-8918441D-23FB-4AFA-B141-462C9B7D346CQ33587143-EEE1D9BD-39B0-4772-81A9-393A9B54D78CQ33594240-CEFC29EC-4EBC-44B2-82CC-15F0B01C0B7FQ33616725-4A50587F-66BB-428C-AA54-54BC8B2E62FDQ35744431-FF4D672C-A784-46D7-B77D-E04C178660B4Q36088515-9B5C0B78-CE62-498D-8C9C-09B0EB4946CBQ36363471-7A36AD88-B41B-4A6D-B8DF-818B148E4E0BQ36566920-81B1D53F-FC44-4887-B33C-4414F4B490C5Q36993598-A06F7DA9-12BF-40E6-BBF0-85E26596F1CAQ37085524-A21F8D65-2318-47EA-9EBD-E334792887C1Q37424194-407021A2-BAF7-4659-8B1A-7C4027ADFF4BQ37690914-6C7F6D0A-85F5-4C2D-A63C-9901352991D7Q37691012-107387B0-9529-4003-B003-6D7FF316E659Q37727924-D44907E6-073A-464E-AFDF-4D1CBE91F509Q38616130-4B9A5765-B5A6-4D43-9A69-45701A608A71Q38803978-87F052D9-1592-4FBC-B7B2-FB2F6D1170EAQ39096258-E8BD9BF4-F6FA-4A79-9AD6-A97F5233D3BBQ39717539-49F7FBB5-7245-4457-88CA-B6B425D9994AQ40279737-14FB818D-B82F-42FB-ABFE-AE5A77374FCDQ40826655-3F397182-FD43-4B0C-84B1-B0B9067EB4B1Q43716185-4FFA24BB-7950-43FF-9E4D-F3AD4949473BQ44136666-8C974218-DAA7-4FC9-939F-74DD234E02F1Q46096261-274198CD-E7AF-4F10-8207-926E5B959D07Q46788949-74C9B6D1-1E6E-4823-A4F8-00057732A7E6Q47601384-F767FC50-EF5A-4ADE-AA62-330AECD7F295Q47612042-F81933BA-FB33-4A11-9624-2B4957332827Q47693285-FF948B28-4079-443F-870B-74239B14C5CAQ47717769-A04A20E4-E99C-43E3-8077-3E3A90825F58Q49978034-255D2A7F-0D20-41F2-A502-222A9062246CQ50759027-3FF0EC2F-E0C1-431C-BE4D-E286E518D0CEQ54215879-E9054815-58AC-46E9-974B-D84520A52290Q54919654-B2C5CCD8-2603-43D1-A36D-9C43B21C7324Q57844779-F79A0B76-5AEB-4423-BF6A-F2286DB2F162Q57844786-977F0044-3D83-44CC-AF52-662C861AEDDCQ57844797-14921748-8578-495A-BD1E-2E734292ABEAQ57844806-A194EC33-24BD-497F-8476-62DBDAA8C36CQ57844830-834DF244-D1B3-4A14-80A9-F549C296F5D1
P50
description
researcher ORCID ID = 0000-0001-7470-528X
@en
name
Chien-Ning Hsu
@ast
Chien-Ning Hsu
@en
Chien-Ning Hsu
@es
Chien-Ning Hsu
@nl
type
label
Chien-Ning Hsu
@ast
Chien-Ning Hsu
@en
Chien-Ning Hsu
@es
Chien-Ning Hsu
@nl
prefLabel
Chien-Ning Hsu
@ast
Chien-Ning Hsu
@en
Chien-Ning Hsu
@es
Chien-Ning Hsu
@nl
P31
P496
0000-0001-7470-528X